Phase 1 Systemic Sclerosis (SSc) trials recruiting now

All Systemic Sclerosis (SSc) trials, every phase

Other phases for Systemic Sclerosis (SSc)

Phase 1 Systemic Sclerosis (SSc) trials

• A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases
  NCT07413341 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
  NCT07104721 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
  NCT06978647 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
  NCT06308978 · Phase: Phase 1 · Ages: 12 Years to 70 Years · Sex: All (male and female) · 21 locations
• A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
  NCT06249438 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases
  NCT06980597 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
  NCT07305116 · Phase: Phase 1 · Ages: 3 Years and older · Sex: All (male and female) · 1 location
• CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases
  NCT06941129 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)
  NCT06822881 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Controlling Hyperactive Immunity With Long-lived Lymphocytes
  NCT07473154 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 10 locations
• FT839 in Autoimmune Diseases
  NCT07800871 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
  NCT07085676 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 2 locations
• Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
  NCT06828042 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• US Zamto-cel Autoimmune Diseases
  NCT06708845 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.